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Objective. Irritable and nonirritable depressed patients diﬀer on demographic and clinical characteristics. We investigated whether
this extends to psychological and physiological measures. Method. We compared irritable and nonirritable unipolar depressed
patients on symptomatology, personality, and (psycho)physiological measures (cortisol, cholesterol, and heart rate variability).
Symptomatology was reassessed after one year, and we also compared depressed patients who were irritable or non-irritable at
both time points (Irr++ versus Irr−−). Results. Almost half (46%; N = 420) of the sample was classiﬁed as irritable. These
patients scored higher on depression severity, anxiety, hypomanic symptoms, and psychological variables. No diﬀerences were
observed on physiological markers after correction for depression severity. The same pattern was found when comparing Irr++
and Irr−− groups. Conclusion. Irritable and non-irritable depressed patients diﬀer on clinical and psychological variables, but not
on the currently investigated physiological markers. The clinical relevance of the distinction and the signiﬁcance of the hypomanic
symptoms remain to be demonstrated.
1.Introduction
Not all symptoms that are prevalent in major depression
are part of its diagnostic criteria [1]. For instance, most
depressed patients experience signiﬁcant levels of anxiety.
Irritability is also reported by many. In children, irritability is
the most common symptom of depression [2] and is one of
the diagnostic criteria. Two recent studies have examined the
clinical signiﬁcance of irritability in depression in adults. In a
community sample of depressed patients, approximately half
of the 955 patients with lifetime unipolar depression were
also irritable during their worst episode [3], as measured
with one item of the Composite International Diagnostic
Interview. Depressed patients scoring positive on irritability
had a younger age of onset and higher rates of comorbid
attention-deﬁcit/hyperactivitydisorder,oppositional-deﬁant
disorder,intermittentexplosivedisorder,dysthymiaandanx-
iety disorders [3]. A second study [4] compared depressed
patients with and without irritability based on the irri-
tability item of a standardized symptom interview. Irritable
depressed patients (N = 1,067; 46%) reported more anxiety,
loneliness and annoyance by daily hassles, and more prior
suicide attempts than nonirritable depressed patients.
Previous research by the same group focused on a
depression subtype characterized by the presence of anger
attacks, in other words by disturbances in the regulation of
irritability [5–7]. Around 40% of depressed outpatients had
one or more anger attacks during the past month [8, 9].2 Depression Research and Treatment
In comparison with depressed patients without anger
attacks, these patients had higher levels of hostility, anxiety,
somatization [9] ,h i g h e rc h o l e s t e r o ll e v e l s[ 10], more axis II
psychopathology [11], increased risk of cardiac dysfunction
[12], and a younger age of depression onset [13]. Depressed
patientswithangerattacksalsoshowedabluntedresponseto
the serotonin (5-HT) agonist fenﬂuramine [14]. Compared
to healthy controls, depressed patients with anger attacks
showed diﬀerential activation of orbitofrontal–limbic cir-
cuits following an anger induction task [15].
Ithasbeensuggestedthatirritabilitymayalsobeafeature
of unrecognized bipolar (spectrum) disorder [16–18]. It has
not been investigated yet to what extent irritability during
a depressive episode predicts the development of bipolar
disorder. However, other features of bipolar disorder, such as
early age of onset, suicidality, family history, greater episode
recurrence, and atypical depression were not found to be
more common in the irritable depressed [4].
The present study had two aims. The ﬁrst aim was to
investigate whether the psychological and biological proﬁle
that has been found for depressed patients with anger
attacks also applies to depressed patients with irritability. We
compared outpatients with irritable and nonirritable unipo-
lar depression on demographic, clinical, psychological, and
biological markers that had previously been associated with
impulsivity, aggression, or anger attacks. These markers in-
clude personality, cognitive reactivity, heart rate variability
[12], cholesterol [10], and cortisol [19]. We hypothesized
that depressed patients reporting irritability would score
higher on anxiety and suicidality, lower on agreeableness,
and higher on aggression reactivity. We also expected that
irritable depression would be associated with lower heart
rate variability, lower cholesterol concentrations, and higher
levelsofcortisol,particularlythecortisolawakeningrise.The
second aim was to investigate the association of irritability
in depression with features of (hypo-)mania. For this, we
measured (hypo-)manic symptoms in the same patients.
2. Methods
2.1.Participants. ParticipantswereselectedfromtheNether-
lands Study of Depression and Anxiety (NESDA). This
cohort study follows 2,981 adult participants over the course
of 8 years [20]. NESDA respondents were recruited from the
community and through primary and secondary care facili-
ties.ThetotalNESDAsamplecontains2,329individualswith
a lifetime diagnosis of depression, dysthymia and/or an anx-
iety disorder, and 652 healthy participants. Participants with
a diagnosis of bipolar disorder, a psychotic disorder, obses-
sive compulsive disorder, or severe addiction disorder are
excluded from NESDA. For the present study, we selected the
913 participants who met the criteria for major depression,
minor depression, or dysthymia during the month prior
to study admission.
2.2. Instruments.
2.2.1. Diagnoses. Current and past DSM-IV diagnoses of
mood disorders, anxiety disorders, and alcohol abuse and
dependency were assessed with the Composite International
Diagnostic Interview (CIDI) [21]. The interviews were con-
ductedandscoredbytrainedandsupervisedclinicalresearch
staﬀ. Psychotic disorders and addictions were assessed in an
open interview and checked in the medical records. Severity
of alcohol dependence and abuse was assessed with the Audit
questionnaire [22].
2.2.2. Symptomatology. Severity of depression during the
past week was deﬁned as the total score on the Inventory
of Depressive Symptomatology (IDS-SR) [23], excluding
the irritability item. Anxiety symptoms were assessed with
the Beck Anxiety Index (BAI) [24]. The BAI measures the
somatic and cognitive aspects of anxiety during the past
week (e.g., “numbness or tingling” and “fear of the worst
happening”). It contains 21 items, scored on a four-point
scale. The symptoms of bipolar disorder were assessed with
the Mood Disorder Questionnaire (MDQ) [25], which
contains 13 items derived from DSM-IV criteria and clinical
experience (e.g., “you were so irritable that you shouted at
people or started ﬁghts or arguments” and “you felt more
self-conﬁdent than usual”).
2.2.3. Irritability. Irritability status was determined using
one item from the Inventory of Depressive Symptoma-
tology—Self-Report (IDS-SR) [23]. This item asks whether
the participant has been “feeling irritable during the past
seven days”. The answers are scored on a four-point scale
with descriptors “not feeling irritable” (1), “feeling irritable
less than half the time” (2), “feeling irritable more than half
the time” (3), or “feeling extremely irritable nearly all of the
time” (4). The sample was split into low (scoring 1 or 2)
(Irr−) and high irritable groups (scoring 3 or 4) (Irr+). The
validity of this criterion has been shown previously in other
cohorts [3, 4], but since the IDS measures past week severity
only, irritability was reassessed at a one-year followup. This
a l l o w e du st oc r e a t es o m e w h a tm o r ee x t r e m es u b g r o u p s
of depressed patients who were irritable both at baseline
and at one-year followup (Irr++) and patients who were
nonirritable on both assessments (Irr−−).
2.2.4. Suicidality. Previous suicide attempts were assessed
with the Beck scale for suicide ideation [26].
2.2.5. Psychological Variables. Cognitive vulnerability to de-
pression was measured with the Leiden Index of Depression
Sensitivity—Revised(LEIDS-R)[27,28].TheLEIDS-R,a34-
item self-report scale, measures cognitive reactivity to sad
mood on the following subscales: hopelessness/suicidality,
acceptance/coping, aggression, control/perfectionism, risk
aversion and rumination. Personality traits were assessed
withtheshortformoftheNEOFiveFactorInventory(NEO-
FFI) [29].
2.3. Physiological Variables.
2.3.1. Cortisol Awakening Rise. Cortisol awakening response
was used to investigate HPA-axis function [30]. During theDepression Research and Treatment 3
baseline assessment, patients were instructed to collect four
cortisol samples on a regular (working) day shortly after
the interview. Samples were taken at awakening and at 30,
45, and 60 minutes after the ﬁrst sample, after which they
were returned by mail after collection. Median time between
the interview and saliva sampling was 9.0 days (25th–27th
percentile, 4–22 days). Outcome measures were the area
under the curve with respect to the ground (AUCg) and the
area under the curve with respect to the increase (AUCi)
[31, 32].
2.3.2. Cholesterol. Total cholesterol, low-density lipoprotein
(LDL) and high-density lipoprotein (HDL), and cholesterol
levels (both measures of serum cholesterol) were assayed
from a blood sample taken after an overnight fast [33].
2.3.3. Heart Rate Variability (HRV). Heart rate variability
(HRV) was assessed using a VU-AMS monitoring system
[34] which was worn during most of the baseline measure-
ment(averageregistration99.9minutes).Thevariousphases
of the session (resting baseline, interviews, and a cognitive
task) were marked using an event button. Mean heart rate,
standard deviation of the interbeat intervals (SDNN), and
the diﬀerent measures of respiratory sinus arrhythmia (RSA)
were calculated from the interbeat interval (IBI) time series
and respiration signal [34–36]. For the current study, we
investigated SDNN and RSA measured in (supine) rest
condition (during which no interview was conducted) and
during performance of a cognitive test (test condition) [37].
2.4. Data Screening. Data were checked for missings and
outliers, normality of distributions, and homogeneity of
variances. 145 of the 913 participants did not return their
questionnaire package resulting in 145 missings on all vari-
ables of the LEIDS-R. On the age of onset variable, 162 par-
ticipants had missing values. In about half of the other vari-
ables, a low number of missing values (<20) were replaced
with the series mean of their subgroup (Irr+/Irr−) according
to Tabachnik and Fidell [38] .T h ed a t a s e tw a sc o m p l e t ef o r
the other variables. After removal of outliers (scores higher
or lower than 2 standard deviations from the mean) [32],
cortisol data were normally distributed. There were no
statisticaloutliers(basedonCook’sdistancesandstudentized
residuals) on any of the other variables.
2.5. Statistical Analyses. Group diﬀerences (Irr+ versus Irr−)
were investigated by general linear models (GLMs). This was
done in two steps. First, data were explored by using separate
univariate GLMs with group (Irr+/Irr−) as the between
subjects factor. Alpha was set at 0.05, however all outcome
variables signiﬁcant at the P<. 15 level in these univari-
ate analyses were entered in a multivariate GLM to take
into account correlations among the dependent variables.
Covariates were included in the univariate and multivariate
analyses in order to reduce error variance [39]. The choice
of covariates in each of the analyses was based on literature
review and results of previous studies conducted in NESDA
[37,40].Age,gender,andcurrentdepressionsymptomswere
included as covariates in the GLMs for the LEIDS-R and
NEO-FFIsubscaleandtotalscores.Forthecortisolmeasures,
we entered physical activity, smoking, cardiovascular disease,
whether the participant was working on the day of data col-
lection and hours of daylight in the month of data collection
as covariates. In the HRV and cholesterol analyses, covariates
were age, gender, depression severity, alcohol dependence
and abuse, use of antidepressants, and heart medication.
Participants were classiﬁed as nonsmoker, former smoker,
smoker, or heavy smoker (>20 tobacco consumptions a
day), and similar categories were made for alcohol use:
nondrinker, mild drinker (<7units/week), moderate drinker
(7–14u/wk),andheavydrinker(≥15u/wk).Energyspenton
physical activity per week was measured with the Inter-
national Physical Activity Questionnaire [41]. Chi-square
statistics were used in case of categorical variables. Logistic
regression analysis was used to control for potential con-
founders in relationships involving categorical variables.
3. Results
3.1. Demographic and Clinical Characteristics. Univariate
analyses showed that the irritable depressed group was
signiﬁcantly older than the nonirritable depressed group
(F(1,911) = 10.7; P = .001). There was no signiﬁcant
diﬀerence in the distribution of males and females over the
two groups (χ2(1) = .004; P = .95). Participants in the Irr+
group had been recruited from specialized mental health
institutions more often than participants in the Irr− group
(χ2(2) = 16.4; P<. 001).
Table 1 showsthattheIrr+groupalsohadnotablyhigher
scores on severity of depression (IDS total minus Item 6;
Irritability) (F(1,911) = 232.9; P<. 001) than the Irr−
group.Thispatternwaspresentateachrecruitmentsite,with
9 points diﬀerence between Irr+ and Irr− in primary care
(F (1,367) = 76.6; P<. 001) and specialized mental health
care (F(1,466) = 102.3; P<. 001) and 13 points diﬀerence
in the general population (F (1,72) = 47.5; P<. 001). Irr+
participants also had higher anxiety (BAI total) symptoms
(F(1,911) = 134.2; P<. 001) and more lifetime anxiety
disorders (χ2(1) = 5.5; P = .019). Current GAD (χ2(1) =
14.7; P<. 001), panic disorder (χ2(1) = 22.8; P<. 001), and
social anxiety disorder (χ2(1) = 17.3; P<. 001) were also
more prevalent in the Irr+ group.
More patients in the Irr+ group had previously at-
tempted suicide than patients in the Irr− group (25% versus
17%; χ2(1) = 8.3; P = .004). However, an additional
logistic regression analysis showed that the association
between irritability and suicidality was no longer statistically
signiﬁcant after controlling for depression severity. Patients
in the Irr+ group scored higher on three mania items of
the MDQ: talkativeness (χ2(1) = 4.03; P = .045), racing
thoughts (χ2(1) = 10.47; P = .001), and distractibility
(χ2(1) = 14.57; P<. 001).
3.2.CognitiveVulnerability. TheIrr+groupscoredhigheron
all subscales of the LEIDS-R, with exception of the accep-
tance subscale. The Irr+ group also had a signiﬁcantly higher4 Depression Research and Treatment
Table 1: Demographic and clinical characteristics of low and high irritable depressed patients: univariate results.
Low irritable (N = 493) High irritable (N = 420)
Demographic features
Age (mean ± SD) 43.4 ± 12.3 40.7 ± 11.7 η2 = .012∗
Sex (% female) 65.9 65.7 OR = 0.99 (CI: 0.75–0.30)
Recruited from:
Specialized mental health care (%) 45.2 58.6 OR = 1.71∗∗ (CI: 1.32–2.23)
Community + primary care (%) 54.8 41.4
Clinical features
Age of onset (mean ± SD)‡ 28.6 ± 13.1 26.6 ± 12.2 η2 = .006∗
Smoking (% yes) 43.4 48.1 OR = 1.21 (CI: 0.93–1.57)
Alcohol (% recent abuse and/or dependence) 8.5 8.1 OR = 0.95 (CI: 0.59–1.52)
Comorbid anxiety (CIDI diagnosis%) 73.6 80.2 OR = 1.45∗ (CI: 1.06–1.99)
GAD (%) 24.9 36.7 OR = 1.74∗∗ (CI: 1.31–2.31)
Panic disorder (%) 22.7 37.1 OR = 2.01∗∗ (CI: 1.51–2.68)
Social phobia (%) 26.2 39.0 OR = 1.82∗∗ (CI: 1.37–2.39)
IDS total score (mean ± SD)a 27.8 ± 10.1 37.7 ± 9.5 η2 = .204∗∗
First degree family history with depression (%) 84.4 85.0 OR = 1.05 (CI: 0.73–1.51)
Beck Anxiety Inventory (mean ± SD) 15.8 ± 9.4 23.8 ± 11.4 η2 = .128∗∗
Suicidality (% ≥1 attempt during lifetime) 17.4 25.2 OR = 1.60∗ (CI: 1.16–2.20)
Low irritable (N = 202) High irritable (N = 138)
MDQ (% yes)
Elated mood 28.8 32.0 OR = 1.20 (CI: 0.88–1.64)
Increased self-conﬁdence 39.4 39.9 OR = 1.02 (CI: 0.76–1.37)
Less sleep needed 42.0 44.0 OR = 1.09 (CI: 0.81–1.45)
More and/or faster speech 50.7 57.5 OR = 1.34 (CI: 1.01–1.79)∗
Racing thoughts 75.6 84.5 OR = 1.84 (CI: 1.27–2.68)∗
Concentration problems 74.6 85.3 OR = 2.06 (CI: 1.41–3.00)∗∗
More energy 44.6 45.7 OR = 1.06 (CI: 0.80–1.42)
Increased activity 49.8 48.7 OR = 0.98 (CI: 0.73–1.30)
Heightened sociability 23.9 28.4 OR = 1.27 (CI: 0.92–1.76)
Increased libido 29.1 32.8 OR = 1.20 (CI: 0.88–1.64)
Risk taking 25.8 32.8 OR = 1.41 (CI: 1.03–1.93)
Financial risk taking 13.4 18.2 OR = 1.45 (CI: 0.98–2.14)
bNEO FFI (mean ± SD)
Neuroticism 40.6 ± 6.6 45.2 ± 6.1 η2 = .009∗
Extraversion 33.9 ± 6.7 31.1 ± 6.6 η2 = .001
Openness 31.1 ± 5.0 30.1 ± 6.0 η2 = .003
Agreeableness 43.5 ± 5.1 41.0 ± 5.6 η2 = .022∗∗
Conscientiousness 35.3 ± 6.2 34.3 ± 6.3 η2 = .001
Low irritable (N = 427) High irritable (N = 341)
bLEIDS-R (mean ± SD)
Hopelessness 6.8 ± 4.8 9.2 ± 5.2 η2 <. 001
Acceptance 1.9 ± 2.2 2.0 ± 2.6 η2 = .002
Aggression 5.0 ± 4.3 8.6 ± 5.1 η2 = .049∗∗
Control 6.4 ± 3.8 7.3 ± 4.1 η2 <. 001
Risk aversion 10.6 ± 4.5 12.0 ± 4.6 η2 = .001
Rumination 11.4 ± 4.7 13.5 ± 4.2 η2 = .002
Total score 42.2 ± 17.5 52.7 ± 17.3 η2 = .004
∗.05 < P >.001.
∗∗P <. 001.
‡N = 751 (low irritable. N = 382, high irritable, N = 369).
aIDS-SR total score minus the score on the irritability item.
bControlled for current symptoms (IDS-total minus item 6), gender, and age.Depression Research and Treatment 5
Table 2: Demographic and clinical characteristics of low and high
irritable depressed patients—multivariate resultsa.
Low irritable
(n = 323)
High irritable
(n = 301)
Age of onset (mean
± SD) 29.0 ± 13.2 26.9 ± 12.4 η2 = .001
Beck Anxiety
Inventory (mean ±
SD)
16.6 ± 9.5 23.9 ± 11.3 η2 = .008∗∗
LEIDS (mean ±
SD)
Aggression 5.0 ± 4.2 8.8 ± 5.1 η2 = .073∗∗∗
NEO FFI (mean ±
SD)
Neuroticism 41.2 ± 6.8 45.3 ± 6.1 η2 = .006∗
Openness 31.1 ± 5.1 30.6 ± 5.9 η2 <. 001
Agreeableness 44.0 ± 5.0 41.4 ± 5.6 η2 = .024∗∗∗
∗.085 < P > .05.
∗∗.05 < P > .001.
∗∗∗P < .001.
aControlled for current symptoms (IDS-total minus item 6), gender, and
age.
LEIDS-R total score (F(1,766) = 68.8; P<. 001). After
adding age, gender, and IDS total score as covariates, only
the diﬀerence between the scores on the aggression subscale
of the LEIDS-R remained signiﬁcant (F(1,763) = 39.4;
P<. 001).
3.3. Personality. The Irr+ group had signiﬁcantly higher
neuroticismscores(F(1,908) = 116.06;P<. 001)andscored
signiﬁcantly lower on extraversion (F(1,908) = 39.48; P<
.001), openness (F(1,909) = 6.71; P = .010), agreeableness
(F(1,908) = 48.58; P<. 001), and conscientiousness
(F(1,908) = 5.38; P = .021) than the Irr- group. After
correctingforage,gender,andtotalIDSscore,thediﬀerences
on neuroticism and agreeableness remained statistically
signiﬁcant.
3.4. Multivariate Analyses. The multivariate analyses (shown
inTable 2)yielded similarresults,withsigniﬁcantdiﬀerences
between Irr+ and Irr− on BAI total score (F(1,619) = 4.84;
P = .028), LEIDS-R aggression (F(1,619) = 48.40; P<
.001), and agreeableness (F(1,619) = 14.96; P<. 001).
Neuroticism was signiﬁcant at trend level (F(1,619) = 3.71;
P = .055).
3.4.1. Physiological Variables. Table 3 shows the outcomes on
the (psycho)physiological markers. There were no signiﬁcant
diﬀerences in cortisol awakening response (CAR) between
the Irr− and Irr+ irritable group. HDL cholesterol was
signiﬁcantly higher in the Irr− group (F(1,911) = 5.69; P =
.017),butthisdiﬀerencewasnolongersigniﬁcantafterenter-
ing the covariates gender, age, smoking, alcohol abuse and
dependence, and antidepressant and heart-medication use.
Both groups did not diﬀer signiﬁcantly on measures of HRV
either (all P values >. 12), with and without correction
Table 3: Psychophysiological measures.
Low irritable
(n = 294)
High irritable
(n = 218 )
Cortisol (mean ±
SD)
aAUCi 1.9 ± 4.9 2.1 ± 5.2 η2 = .001
bAUCg 18.1 ± 6.2 18.2 ± 5.8 η2 <. 001
(n = 487 ) (n = 419)
cCholesterol (mean
± SD)
Total cholesterol 5.2 ± 1.1 5.1 ± 1.1 η2 = .001
LDL cholesterol 3.2 ± 1.0 3.2 ± 1.0 η2 <. 001
HDL cholesterol 1.6 ± 0.4 1.6 ± 0.4 η2 = .001
(n = 470) (n = 404)
dHeart rate
variability (mean
± SD)
RSArest 41.9 ± 27.7 45.6 ± 29.6 η2 = .002
RSAtest 40.8 ± 23.0 43.4 ± 23.9 η2 = .001
SDNNrest 71.2 ± 30.9 73.3 ± 31.8 η2 = .001
SDNNtest 62.2 ± 23.1 63.9 ± 22.9 η2 = .002
aControlled for sex, physical activity, cardiovascular disease, time of awak-
ening, and hours of sleep.
bControlled for smoking, physical activity, cardiovascular disease, working
on testing day, and hours of daylight in month of testing.
cControlled for current symptoms (IDS-total minus item 6), sex, age,
smoking, alcohol abuse and dependence, and antidepressant use.
dControlledforcurrentsymptoms(IDS-totalminusitem6),sex,age,smok-
ing, alcohol abuse and dependence, antidepressant and heart medication-
use, and heart disease.
for presence of cardiac disease or use of heart medication.
Presence of cardiac disease (5.7% versus 6.7%) and use
of heart medication (13.3% versus 16.2%) did not diﬀer
signiﬁcantly between depressed patients with and without
irritability.
3.4.2. Irritability at One-Year Followup. Depressed patients
who were irritable both at baseline and at one-year followup
(Irr++) (N = 138) diﬀered from depressed patients who
were nonirritable on both baseline and one-year followup
(Irr−−)( N = 202) on largely the same outcomes. Fewer
patients in the Irr++ group were recruited from primary
health care or the community (χ2(1) = 5.67; P = .020),
and they scored higher on comorbid anxiety disorders. Their
depression severity (IDS minus irritability) was also higher
(F(1,338) = 77.74; P<. 001). They scored higher on ag-
gression reactivity (F(1,319) = 36.35; P<. 001) and total
LEIDS-R score (F(1,319) = 3.94; P = .048), after correction
for depression severity, age, and gender. Irr++ participants
also had higher neuroticism (F(1,335) = 12.94; P<. 001)
and lower agreeableness (F(1,335) = 8.62; P = .004) scores,
after correction for age, gender, and depression severity. No
physiological diﬀerences were found between the Irr++ and
Irr−− groups.6 Depression Research and Treatment
4. Discussion
The present study showed that approximately half of the
patients withaprimary diagnosis ofunipolar depression also
have high levels of irritability. This is consistent with earlier
research [3, 4]. Other studies have shown that the prevalence
of anger attacks in patients with unipolar depression is only
slightly lower at approximately 40% [6, 9, 42]. These studies,
however, concerned patients recruited from secondary care
facilities. In the current study, almost 60% of the patients
recruited from psychiatric outpatient departments were
classiﬁedasirritable.Irritabilityhasbeendeﬁnedas“afeeling
characterized by reduced control of temper” which often
results in verbal or behavioral aggression [43]. Although
irritability should be distinguished from more violent forms
of aggressive and assaultive behavior, milder and more
severe forms of irritability (e.g., anger attacks) may lie on a
continuum [43]. Future research may investigate the exact
relationship between irritability during depression and its
outward manifestations such as anger attacks.
4.1. Clinical Characteristics of Irritable versus Nonirritable
Depression. Irritable depressed patients were more severely
depressed than nonirritable depressed patients. The diﬀer-
ence in IDS scores was 10 points, which is more than one
standard deviation. The severity of anxiety symptoms and
suicidality was also higher. Moreover, irritable depressed
patients were more often diagnosed with a comorbid anxiety
disorder. The onset of depression was approximately two
years earlier in the irritable depressed. They were also
somewhatolderatstudyentryandweremoreoftenrecruited
from secondary care facilities. With regards to their psycho-
logical proﬁle, diﬀerences between irritable and nonirritable
depressed patients were observed on a broad range of per-
sonality traits and cognitive vulnerability indices. However,
after correction for depression severity, irritable depressed
patients only had higher scores of aggression reactivity and
lower scores of the personality trait agreeableness. Although
participants are categorized into high- and low-irritable
groups on the basis of one symptom, the psychological
proﬁle observed in the present study supports the validity of
the subgroups.
4.2. Physiological Diﬀerences between Irritable and Nonir-
ritable Depression. We found no diﬀerences between irri-
table and nonirritable depressed patients on any of the
physiological markers that were investigated. Although HDL
cholesterol was signiﬁcantly higher in nonirritable patients,
this result was no longer signiﬁcant after correction for
several covariates. No diﬀerences were observed on measures
of heart rate variability (HRV) and cortisol awakening rise
(CAR). We subsequently investigated the possibility that
these physiological markers are related to more stringently
deﬁned subtypes, by selecting participants who were also
depressed at one-year followup and showed either high or
lowscoresofirritabilityatbothtimepoints.Thiscomparison
produced exactly the same pattern of ﬁndings. Irritable
depressed patients had a greater prevalence of anxiety
disorders and higher depression severity and aggression
reactivity. Again, no diﬀerences were found on any of the
physiologicalmeasuresaftercorrectionforoveralldepression
severity. The absence of diﬀerences at the physiological level
was unexpected since studies in healthy samples have found
greater HPA-axis reactivity [44, 45] and increased cardiac
reactivity as a function of hostility and aggression [46, 47].
However, in a population-based sample anxiety and hostility
were not related with HRV but with baroreﬂex sensitivity,
which may be a more sensitive measure of vagal activity
[47]. In depressed patients, the studies that investigated car-
diac and HPA-axis reactivity concern comparisons between
patients with and without anger attacks. These studies found
higher cholesterol concentrations in depressed patients with
anger attacks [48]. We found no support for this ﬁnding in
the present sample of irritable versus nonirritable depressed
patients.
In the present study, HRV was assessed at rest and during
a task that required cognitive eﬀort. Cortisol samples were
collected at home. It has been suggested that depressed
patientswithanxiety-aggressionbehaviorsalsohaveagreater
sensitivity to stress [49]. It could be that irritable depressed
patients only show greater HPA-axis and cardiac reactivity
when exposed to a more signiﬁcant stressor than performing
a cognitive test. This could be further tested using the
same measures as in the present study in combination with
laboratory stress or anger induction paradigms.
The clinical and psychological characteristics observed
in the irritable depressed patients resemble a subtype of
depression proposed by Van Praag [49–51]. He stated that
aggression combined with anxiety is the primary feature
of a subtype of depression which he called “stressor-
precipitated, cortisol-induced, serotonin-related, anxiety/ag-
gression-driven” (SeCA) depression [19]. This subtype may
be further characterized by increased 5-HT disturbances, in
which low mood is a secondary symptom [50]a n dw i t h
aggressiondisturbancesasprimarysymptom.Unfortunately,
markers of 5-HT function were not available in the present
study.
4.3. Symptoms of Bipolar Disorder in Irritable versus Non-
irritable Depression. We also observed diﬀerences between
irritable and nonirritable depressed patients on three symp-
toms of hypomania as measured by the MDQ: distractibility,
talkativeness, and racing thoughts. Future longitudinal anal-
yses of NESDA participants may show whether irritability
during depression is a risk factor for the development of
bipolar disorder.
4.4. Strengths and Limitations of the Current Study. The
current study had several strengths, including a rather large
sample size of currently depressed patients. Diagnoses were
determined using a standardized interview. Patients were
recruited from diﬀerent sites and facilities, which increases
the generalizability of the ﬁndings. The cross-sectional
design is a limitation. This was partially remediated by the
inclusionofaone-yearfollowupmeasurementoftheclinical
variables, which allowed us to investigate a more stableDepression Research and Treatment 7
subgroup of irritable depressed patients. Although other
studies used the same method [3, 4], the fact that the
distinction between irritable and nonirritable depressed was
based on just one symptom can be seen as a limitation. We
interpret the selective diﬀerences on cognitive reactivity and
personality as supporting the validity of the distinction.
4.5. Future Directions. Our ﬁndings indicate several clinical
diﬀerences between depressed patients with and without
irritability. High levels of irritability during depression are
associated with more severe depression, higher levels of anx-
iety, and more comorbid anxiety disorders. Anxiety during
depression is associated with poorer outcome, including
higher risk of chronic depression, poorer treatment response
[52], and increased suicide incidence [53]. Moreover, we
foundhigherlevelsofaggressionreactivity,hopelessness,and
disagreeableness in irritable depressed patients. Both hope-
lessness and aggression reactivity have been associated with
increased suicide risk [54]. Therefore, it is important to con-
tinue the investigation into possible underlying mechanisms
of this form of depression. There is evidence that depressed
patients with aggression dysregulation problems have more
pronounced 5-HT alterations [49, 50, 55–57]. Moreover,
there is some evidence that depression in combination with
aggression (hostility, anger) is partly under genetic control
[58].
5. Conclusion
In this cross-sectional assessment, approximately half of
depressed patients were classiﬁed as irritable. These patients
diﬀer from low-irritable depressed patients on several other
aspects of the clinical presentation, including depression
severity and comorbid anxiety. Personality and cognitive
vulnerability measures also diﬀer between these groups.
Future longitudinal studies in depressed patients are needed
to investigate the consequences of high levels of irritability in
terms of risk of bipolar disorder, course of disease and treat-
ment response.
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